Mounjaro (tirzepatide) is a once-weekly injectable prescription drug that is approved by the Food and Drug Administration (FDA) for use in adults with Type 2 diabetes
adults reported that they had previously used a GLP-1 medication (Montero, et al., 2024), which has been increasing in popularity (e.g., Regalado, 2024
The 16-week titration protocol for Wegovy effectively manages GI tolerability
Oral tablets, especially with absorption issues, offer much lower and more variable bioavailability, working more slowly
Another study reported that subjects using liraglutide, a GLP-1 RA, had attenuated responses in the cortex and insular regions of the brain when exposed to images of food in the fasting state compared to the control group [6]
doi: 10.1016/j.lfs.2021.119942 12 BarnesRPFouquerelEOpreskoPL